Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
5.48
-0.04 (-0.64%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Decoy Therapeutics Employees
Decoy Therapeutics had 11 employees as of December 31, 2025. The number of employees increased by 9 or 450.00% compared to the previous year.
Employees
11
Change (1Y)
9
Growth (1Y)
450.00%
Revenue / Employee
n/a
Profits / Employee
-$1,138,044
Market Cap
2.91M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 36 |
| Scinai Immunotherapeutics | 31 |
| Calidi Biotherapeutics | 29 |
| Virax Biolabs Group | 19 |
| GeoVax Labs | 17 |
| Silexion Therapeutics | 14 |
| Azitra | 13 |
| GRI Bio | 4 |
DCOY News
- 1 day ago - Decoy Therapeutics to Present at Two Peptide Therapeutics Conferences in Boston - PRNewsWire
- 19 days ago - Decoy Therapeutics Transcript: Status update - Transcripts
- 19 days ago - Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline - PRNewsWire
- 22 days ago - Decoy Therapeutics to Participate in Virtual Investor Closing Bell Event Highlighting Business Outlook for 2026 - PRNewsWire
- 26 days ago - Decoy Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - PRNewsWire
- 6 weeks ago - Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform - PRNewsWire
- 7 weeks ago - Decoy Therapeutics Announces 1-for-12 Reverse Stock Split - PRNewsWire
- 2 months ago - Decoy Therapeutics Joins Webull Corporate Connect Service Platform - PRNewsWire